2021 CSL Centenary Fellowships

Applications are now open for the 2021 CSL Centenary Fellowships, which are offered to outstanding mid-career scientists seek…

CSL’s Global Role in Battling COVID-19

Here is how CSL is working around the world with academia, industry and governments to combat the novel coronavirus COVID-19 …

Development of COVID-19 immunoglobulin commences

Plasma-derived therapeutic with potential to treat serious complications of COVID-19.

COVID-19 Update

CSL continues to provide medicines to patients around the world.

CSL Behring and SAB Biotherapeutics Join Forces

King of Prussia, Pa. and Sioux Falls, S.D. COVID-19 treatment candidate, a high-potency immunotherapy delivering human pol…

Collaborating on Potential COVID-19 Therapy

Osaka, JAPAN, and King of Prussia, PA, USA Partnership brings together world-leading plasma companies to focus on developi…

Our Offer To Help Battle Coronavirus

To speed treatments, global biotech leader CSL offers to lend the company’s expertise in science and manufacturing.

CSL Media Statement on Coronavirus

CSL Limited's statement on Coronavirus